Sign In
Last checked at 
3 Mar 2026 16:04
Tristel plc
("Tristel" or the "Company")
PCA Dealing
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that it was notified on 3 March 2026 that Glenn Stephens, a PCA of Caroline Stephens, Non-Executive Director of the Company, purchased 2,310 ordinary shares of 1 penny each in the Company ("Ordinary Shares") at a price of 389 pence per Ordinary Share.
Following the purchase, Caroline Stephens' beneficial interest in the Company, including those held by her PCA, is 4,281 Ordinary Shares, representing approximately 0.01 per cent. of the Company's issued share capital.
For further information please contact:
Tristel plc | Via Walbrook PR | |||
Matt Sassone, Chief Executive Officer | www.investors.tristel.com | |||
Anna Wasyl, Chief Financial Officer | ||||
Walbrook PR Ltd | Tel: 020 7933 8780 or tristel@walbrookpr.com | |||
Paul McManus / Lianne Applegarth / Anna Dunphy | Mob: 07980 541 893/ 07584 391 303/ 07876 741 001 | |||
Cavendish Capital Markets Ltd | Tel: 020 7220 0500 | |||
Geoff Nash / Callum Davidson / Joe Smith (Corporate Finance) | ||||
Sunila de Silva (Corporate Broking) / Louise Talbot (Sales) | ||||
About Tristel plc
Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals with products under the Tristel brand, which also encompasses its sporicidal surface disinfection range offered as a sustainable alternative to commonly used pre?wetted plastic wipe.
Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 270 people across 16 subsidiaries selling into 40+ countries. The Company targets delivering double-digit revenue growth annually, an adjusted EBITDA margin of at least 25% and a continuing progressive year-on-year growth in dividends, underpinned by robust cash generation.
The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL).
For more information about Tristel's product range please visit: https://tristel.com
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||||
a)
| Name
| Glenn Stephens | ||||||
2
| Reason for the notification
| |||||||
a)
| Position/status
| PCA of Caroline Stephens, Non-Executive Director of the Company | ||||||
b)
| Initial notification /Amendment
| Initial notification | ||||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||||
a)
| Name
| Tristel plc | ||||||
b)
| LEI
| 2138009DZ4LH9CZGF662 | ||||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary Shares of 1p each in Tristel plc
GB00B07RVT99 | ||||||
b)
| Nature of the transaction
| Purchase of Ordinary Shares | ||||||
c)
| Price(s) and volume(s)
|
| ||||||
d)
| Aggregated information
- Aggregated volume
- Price
|
2,310 Ordinary Shares of 1 penny each
389 pence
| ||||||
e)
| Date of the transaction
| 3 March 2026 | ||||||
f)
| Place of the transaction
| London Stock Exchange (AIM)
| ||||||
Follow the stocks
